Recent Updates
Recently added Catalysts
PTCT

PTC Therapeutics to Participate at Upcoming Investor Conferences PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen Virtual 42nd...

Key Takeaway: SOUTH PLAINFIELD, N.J. , Feb. 23, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that management will present a company update at the following conferences: Cowen Virtual 42nd Annual Health Care Conference Monday, March 7 at 1:30 p.m. ET Barclays Gl
Price reaction · baseline $38.45 (2022-02-22 close) · hit after-hours · clean, no other PTCT news in the window
day 0 close
-7.3%
day 1
-6.3%
day 3 · peak
-8.7%

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+74%
120-day peak, hindsight
Typical move
6.6%
average across 4 past catalysts
Lead asset
Ataluren
Phase 3 · Cystic Fibrosis

Full Press Release Details

SOUTH PLAINFIELD, N.J. , Feb. 23, 2022 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT ) today announced that management will present a company update at the following conferences:
Cowen Virtual 42nd Annual Health Care Conference Monday, March 7 at 1:30 p.m. ET
Barclays Global Healthcare Conference Thursday, March 17 at 8 a.m. ET
The presentations will be webcast live on the Events and Presentations page under the Investor section of PTC Therapeutics' website at https://ir.ptcbio.com/events-presentations and will be archived for 30 days following the presentation. It is recommended that users connect to PTC's website several minutes prior to the start of the webcast to ensure a timely connection.
For More Information:
Last updated: Feb 23, 2022